|
Sequences
The following sequences are available for this feature:
mRNA from alignment at KZ851919.1:580414..581503- Legend: exonfive_prime_UTRpolypeptideCDSthree_prime_UTR Hold the cursor over a type above to highlight its positions in the sequence below. >M747DRAFT_64157-T1 ID=M747DRAFT_64157-T1|Name=M747DRAFT_64157-T1|organism=Aspergillus niger ATCC 13496|type=mRNA|length=1090bp|location=Sequence derived from alignment at KZ851919.1:580414..581503- (Aspergillus niger ATCC 13496) GCCATTCCCTCAGCCCCGCCTCCAATTCCGCAAAGCAACGAGGGGCACAT
TTCTCCAAGACAACCACCTTCCTCATACAAGACAACCAACCCGAAAATAC
CAGCCAACATGCATTCCCCTTTGGATCCAACCCTTCAATTCGACTCTATT
GAGGACACAATAGCGGCCTTTAGTGAGTCCCCCAGCTCCAGAACTTCCCA
CCCGCGCCGGCGCGGGAGGCAAATCCATCCCACCACATTCATTACACATA
CAAACAACATCCATGTAACTAACAAGCACACCAATGCACCAGAGAACGGC
GAATTCATCATCGTGCTCGATTCCCAAGACCGCGAAAATGAAGGCGATCT
CATCATTGCCGCTGACTCCATCACTCCGGCGCAGATGGCTTTCCTTGTTC
GCCACACAAGGTAAATCCCCCATTTCCCCCACCTCCTTTCCCCACGAGCA
CATCAAATGTTACTTAACGGGATCACCAATGCTAATGATGGATGAATAGT
GGCCTGATATGCGCCCCCGTCACCCCCGAAATAGCCACCCGCCTCGCCCT
CCCTCAAATGGTCACCGAGAACGCTGATCCTAAGGGAACCGCGTACACCG
TCTCCGTCGACGCAGCTGACCCCTCTATAACAACTGGTATCTCGGCACAA
GACCGCGCTCTTGCCTGTAGGATCCTGGGATCGCCGACATCCACGGCAGC
GGATCTGCGCCGACCCGGTCATGTAATTCCGCTACAGGCCAGACCCGGAG
GTGTCAGGGAACGCACGGGACATACAGAGGCGGCAGTGGAGTTCTGTCGG
TTGGCGGGCAAGACGCAGGCGGGTGTCATCGCGGAACTTGTGGAGGATGG
AGAGGTCGTACCGGGAGTTCCAGAAATTGGGGGTAACAATGGGATGATGA
GACGGGATGGATGCTTGAGGTTTGGAAAGAAGTGGGGGATCAAGGTATGT
ACGATTGAGGATTTGGTGGAGTATGTTGAGAGGGTGGAGGGTGCTGGCGC
TGTGAATGGGAACTGAGTGAGTGTTGACTTGTTCCTTTTTATCTGGTTTT
CTTTTCTTCATCGCCTCTCTTGCATATCTTTCTCTTCGAT back to topCoding sequence (CDS) from alignment at KZ851919.1:580414..581503- >M747DRAFT_64157-T1 ID=M747DRAFT_64157-T1|Name=M747DRAFT_64157-T1|organism=Aspergillus niger ATCC 13496|type=CDS|length=2097bp|location=Sequence derived from alignment at KZ851919.1:580414..581503- (Aspergillus niger ATCC 13496) TGGCCTGATATGCGCCCCCGTCACCCCCGAAATAGCCACCCGCCTCGCCC TCCCTCAAATGGTCACCGAGAACGCTGATCCTAAGGGAACCGCGTACACC GTCTCCGTCGACGCAGCTGACCCCTCTATAACAACTGGTATCTCGGCACA AGACCGCGCTCTTGCCTGTAGGATCCTGGGATCGCCGACATCCACGGCAG CGGATCTGCGCCGACCCGGTCATGTAATTCCGCTACAGGCCAGACCCGGA GGTGTCAGGGAACGCACGGGACATACAGAGGCGGCAGTGGAGTTCTGTCG GTTGGCGGGCAAGACGCAGGCGGGTGTCATCGCGGAACTTGTGGAGGATG GAGAGGTCGTACCGGGAGTTCCAGAAATTGGGGGTAACAATGGGATGATG AGACGGGATGGATGCTTGAGGTTTGGAAAGAAGTGGGGGATCAAGGTATG TACGATTGAGGATTTGGTGGAGTATGTTGAGAGGGTGGAGGGTGCTGGCG CTGTGAATGGGAACTGAAGAACGGCGAATTCATCATCGTGCTCGATTCCC AAGACCGCGAAAATGAAGGCGATCTCATCATTGCCGCTGACTCCATCACT CCGGCGCAGATGGCTTTCCTTGTTCGCCACACAAGATGCATTCCCCTTTG GATCCAACCCTTCAATTCGACTCTATTGAGGACACAATAGCGGCCTTTAT GGCCTGATATGCGCCCCCGTCACCCCCGAAATAGCCACCCGCCTCGCCCT CCCTCAAATGGTCACCGAGAACGCTGATCCTAAGGGAACCGCGTACACCG TCTCCGTCGACGCAGCTGACCCCTCTATAACAACTGGTATCTCGGCACAA GACCGCGCTCTTGCCTGTAGGATCCTGGGATCGCCGACATCCACGGCAGC GGATCTGCGCCGACCCGGTCATGTAATTCCGCTACAGGCCAGACCCGGAG GTGTCAGGGAACGCACGGGACATACAGAGGCGGCAGTGGAGTTCTGTCGG TTGGCGGGCAAGACGCAGGCGGGTGTCATCGCGGAACTTGTGGAGGATGG AGAGGTCGTACCGGGAGTTCCAGAAATTGGGGGTAACAATGGGATGATGA GACGGGATGGATGCTTGAGGTTTGGAAAGAAGTGGGGGATCAAGGTATGT ACGATTGAGGATTTGGTGGAGTATGTTGAGAGGGTGGAGGGTGCTGGCGC TGTGAATGGGAACTGAAGAACGGCGAATTCATCATCGTGCTCGATTCCCA AGACCGCGAAAATGAAGGCGATCTCATCATTGCCGCTGACTCCATCACTC CGGCGCAGATGGCTTTCCTTGTTCGCCACACAAGATGCATTCCCCTTTGG ATCCAACCCTTCAATTCGACTCTATTGAGGACACAATAGCGGCCTTTATG GCCTGATATGCGCCCCCGTCACCCCCGAAATAGCCACCCGCCTCGCCCTC CCTCAAATGGTCACCGAGAACGCTGATCCTAAGGGAACCGCGTACACCGT CTCCGTCGACGCAGCTGACCCCTCTATAACAACTGGTATCTCGGCACAAG ACCGCGCTCTTGCCTGTAGGATCCTGGGATCGCCGACATCCACGGCAGCG GATCTGCGCCGACCCGGTCATGTAATTCCGCTACAGGCCAGACCCGGAGG TGTCAGGGAACGCACGGGACATACAGAGGCGGCAGTGGAGTTCTGTCGGT TGGCGGGCAAGACGCAGGCGGGTGTCATCGCGGAACTTGTGGAGGATGGA GAGGTCGTACCGGGAGTTCCAGAAATTGGGGGTAACAATGGGATGATGAG ACGGGATGGATGCTTGAGGTTTGGAAAGAAGTGGGGGATCAAGGTATGTA CGATTGAGGATTTGGTGGAGTATGTTGAGAGGGTGGAGGGTGCTGGCGCT GTGAATGGGAACTGAAGAACGGCGAATTCATCATCGTGCTCGATTCCCAA GACCGCGAAAATGAAGGCGATCTCATCATTGCCGCTGACTCCATCACTCC GGCGCAGATGGCTTTCCTTGTTCGCCACACAAGATGCATTCCCCTTTGGA TCCAACCCTTCAATTCGACTCTATTGAGGACACAATAGCGGCCTTTA back to top
Annotated Terms
The following terms have been associated with this mRNA:
Vocabulary: Biological Process
Term | Definition |
GO:0009231 | riboflavin biosynthetic process |
Vocabulary: Molecular Function
Term | Definition |
GO:0008686 | 3,4-dihydroxy-2-butanone-4-phosphate synthase activity |
Relationships
This mRNA is a part of the following gene feature(s):
The following polypeptide feature(s) derives from this mRNA:
The following CDS feature(s) are a part of this mRNA:
The following three_prime_UTR feature(s) are a part of this mRNA:
The following exon feature(s) are a part of this mRNA:
The following five_prime_UTR feature(s) are a part of this mRNA:
Properties
Property Name | Value |
Note | BUSCO:EOG09263Z8I |
DBxref | InterPro:IPR017945 |
DBxref | InterPro:IPR000422 |
DBxref | PFAM:PF00926 |
Product | 4-dihydroxy 2-butanone 4-phosphate synthase |
Product | 3 |
Analyses
This mRNA is derived from or has results from the following analyses
Alignments
The following features are aligned
Aligned Feature | Feature Type | Alignment Location |
KZ851919.1 | supercontig | KZ851919.1:580414..581503 - |
|